About
Technology
Issues
FAQ
Links
Official Page
Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
